Who Can Benefit From Spravato Therapy in Columbia, MO?

Spravato therapy is intended for specific forms of depression in adults. Eligibility is determined through a psychiatric and medical evaluation that considers the patient’s diagnosis, previous treatment response, current medications, overall health, and potential safety risks.

Conditions that may qualify include:

• Treatment-resistant depression: Adults with major depressive disorder whose symptoms have not improved adequately after trying at least two oral antidepressant treatments. Spravato may be used alone or with an oral antidepressant for this condition.
• Major depressive disorder with acute suicidal thoughts or behavior: Spravato may be used with an oral antidepressant to treat depressive symptoms in adults experiencing an urgent suicidal crisis.
• Persistent depressive symptoms despite standard care: Adults who continue to experience significant depression after appropriate medication trials may be evaluated for treatment-resistant depression and possible Spravato therapy.

At Success Health System LLC, board-certified psychiatrist Dr. Moses Tabe Ambilichu, M.D., provides individualized evaluations to determine whether Spravato therapy may be suitable for a patient’s symptoms, treatment history, and overall mental health needs.

A Spravato treatment session takes place in a supervised healthcare setting rather than at home. Patients receive the prescribed nasal spray under direct observation and remain at the clinic afterward so the healthcare team can monitor their response and determine when they are ready to leave safely.

During a Spravato treatment session, patients can expect:

• A review of their current health, medications, and any changes in symptoms.
• A blood pressure check before the medication is administered.
• Instructions to avoid food for at least two hours and liquids for at least 30 minutes before treatment.
• Self-administration of the Spravato nasal spray under a healthcare provider’s direct supervision.
• Additional nasal spray devices when needed, based on the prescribed dose.
• A comfortable observation period after receiving the medication.
• Monitoring for sleepiness, dizziness, nausea, changes in perception, dissociation, or breathing problems.
• Blood pressure monitoring, including another check approximately 40 minutes after the dose.
• Monitoring of breathing and oxygen levels during the observation period.
• At least two hours of post-treatment monitoring before discharge.
• A final assessment to confirm that the patient is clinically stable and ready to leave.
• Instructions not to drive, operate machinery, or perform activities requiring full alertness until the following day after restful sleep.
• The need to arrange transportation home after every treatment session.

At Success Health System LLC, board-certified psychiatrist Dr. Moses Tabe Ambilichu, M.D., provides individualized guidance throughout the Spravato treatment process. We review each patient’s response, monitor progress and potential side effects, and coordinate treatment with the patient’s broader mental health care plan.

Spravato therapy may offer an additional treatment option for adults whose depression has not improved adequately with standard antidepressant medications. It uses esketamine, which acts differently from traditional antidepressants, and is administered as a nasal spray in a certified healthcare setting. For treatment-resistant depression, Spravato may be prescribed alone or together with an oral antidepressant, depending on the patient’s needs.

Potential benefits of Spravato therapy may include:

• Providing another option when two or more antidepressant treatments have not produced adequate improvement.
• Targeting a different brain pathway than conventional antidepressant medications.
• Helping reduce depression symptoms in some patients with treatment-resistant depression.
• Producing symptom improvement relatively early for some patients, although individual responses and timing vary.
• Offering the flexibility to be used alone or with an oral antidepressant for treatment-resistant depression.
• Supporting treatment for depressive symptoms in certain adults with major depressive disorder and acute suicidal thoughts or behaviors when used with an oral antidepressant.
• Allowing the provider to monitor each dose, treatment response, blood pressure, and possible side effects in a supervised setting.
• Providing regular opportunities to review progress and coordinate Spravato with the patient’s broader mental health treatment plan.

At Success Health System LLC, we evaluate each patient’s diagnosis, previous treatment response, medical history, current medications, and overall health to determine whether Spravato therapy may be an appropriate option for managing depression.

Spravato therapy can be incorporated into a personalized mental health plan for eligible adults with treatment-resistant depression. Depending on the patient’s diagnosis and needs, it may be prescribed alone or alongside an oral antidepressant. For adults with major depressive disorder and acute suicidal thoughts or behaviors, it is used together with an oral antidepressant.

Before recommending Spravato, the provider reviews the patient’s symptoms, medical and psychiatric history, previous antidepressant treatments, current medications, blood pressure, safety considerations, and personal treatment goals. Spravato sessions take place in a certified healthcare setting, where each dose is supervised, and the patient is monitored for at least two hours for possible effects such as sedation, dissociation, breathing changes, or increased blood pressure.

At Success Health System LLC, board-certified psychiatrist Dr. Moses Tabe Ambilichu, M.D., can determine whether Spravato is appropriate and coordinate it with medication management, therapeutic support, symptom monitoring, and follow-up care. The treatment plan can be adjusted according to the patient’s progress, response, side effects, and long-term mental health needs.

Board-certified psychiatrist Dr. Moses Tabe Ambilichu, M.D., provides individualized evaluations for patients considering Spravato therapy at Success Health System LLC in Columbia, MO. He carefully reviews each patient’s depression symptoms, medical and psychiatric history, previous treatment responses, current medications, and overall health to determine whether Spravato may be an appropriate part of their mental health care plan.

Throughout treatment, Dr. Ambilichu focuses on patient safety, careful monitoring, and ongoing communication. He evaluates treatment progress, discusses possible side effects, and adjusts the broader care plan according to each patient’s response and needs. His personalized approach helps ensure that Spravato therapy is coordinated with continued psychiatric care to support meaningful and lasting improvements in mental well-being.

For more information, contact us or request an appointment online today. We are conveniently located at 3600 I-70 Dr SE- Ste C, Columbia, MO, 65201. We serve patients from Columbia MO, Shaw MO, Harg MO, Deer Park MO, Midway MO, Thornbrook MO and surrounding areas.